Literature DB >> 2677730

Oral hypoglycemic agents.

J E Gerich1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2677730     DOI： 10.1056/NEJM198911023211805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  73 in total

1.  Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes.

Authors:  M Collin; J C Mucklow
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 2.  Modern pharmacotherapies for type 2 diabetes mellitus.

Authors:  S H Hsia
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

Review 3.  Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments.

Authors:  A J Scheen
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 4.  Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors:  J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 5.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

6.  Development of a replicated database of DHCP data for evaluation of drug use.

Authors:  S E Graber; J A Seneker; A A Stahl; K O Franklin; T E Neel; R A Miller
Journal:  J Am Med Inform Assoc       Date:  1996 Mar-Apr       Impact factor: 4.497

7.  Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1.

Authors:  G G Holz; C A Leech; J F Habener
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

Review 8.  Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.

Authors:  C Oosterwijk; J W Höppener; K L van Hulst; C J Lips
Journal:  Int J Pancreatol       Date:  1995-08

Review 9.  Management of antidiabetic medications in overdose.

Authors:  H A Spiller
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

10.  Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients.

Authors:  Christopher Olutayo Alebiosu; Olatunde Odusan; Alfred Jaiyesimi
Journal:  J Natl Med Assoc       Date:  2003-11       Impact factor: 1.798
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.